Cargando…

Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders

Detalles Bibliográficos
Autores principales: Teijeiro, Ana, Djouder, Nabil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361639/
https://www.ncbi.nlm.nih.gov/pubmed/28484725
http://dx.doi.org/10.18632/oncoscience.338
_version_ 1782516804218781696
author Teijeiro, Ana
Djouder, Nabil
author_facet Teijeiro, Ana
Djouder, Nabil
author_sort Teijeiro, Ana
collection PubMed
description
format Online
Article
Text
id pubmed-5361639
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53616392017-05-08 Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders Teijeiro, Ana Djouder, Nabil Oncoscience Editorial Impact Journals LLC 2017-02-24 /pmc/articles/PMC5361639/ /pubmed/28484725 http://dx.doi.org/10.18632/oncoscience.338 Text en Copyright: © 2017 Teijeiro and Djouder http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial
Teijeiro, Ana
Djouder, Nabil
Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title_full Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title_fullStr Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title_full_unstemmed Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title_short Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
title_sort nicotinamide riboside or il-17a signaling blockers to prevent liver disorders
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361639/
https://www.ncbi.nlm.nih.gov/pubmed/28484725
http://dx.doi.org/10.18632/oncoscience.338
work_keys_str_mv AT teijeiroana nicotinamideribosideoril17asignalingblockerstopreventliverdisorders
AT djoudernabil nicotinamideribosideoril17asignalingblockerstopreventliverdisorders